The pluripotent epiblast gives rise to all tissues and organs in an adult body. Its differentiation starts 20 at gastrulation when the epiblast generates mesoderm and endoderm germ layers through a process 21 called epithelial-mesenchymal transition (EMT). Although gastrulation EMT coincides with loss of 22 epiblast pluripotency, pluripotent cells in development and in vitro can adopt either mesenchymal or 23 epithelial morphology. The relationship between epiblast's cellular morphology and its pluripotency is 24 not well understood. In this work, using chicken epiblast and mammalian pluripotency stem cell (PSC) 25 models, we show that PSCs undergo a mesenchymal-epithelial transition (MET) prior to EMT-26 associated pluripotency loss. Epiblast MET and its subsequent EMT are two distinct processes. The 27
INTRODUCTION

35
A human embryo at late blastocyst stage of development contains three cell populations: the CDX2 + 36 trophectoderm, GATA6 + primitive endoderm and POU5F1 + epiblast (1, 2) . Among them, the epiblast is 37 the only pluripotent population which will give rise to all cell lineages in an adult body. Implantation 38 takes place soon afterwards and loss of pluripotency coincides with the onset of gastrulation when the 39 epiblast initiates lineage differentiation by generating the three definitive germ layers (ectoderm, 40 mesoderm and endoderm). Between pre-implantation and gastrulation (about one week in human 41 development), the epiblast is considered to be pluripotent throughout. But due to ethical and technical 42 limitations, morphogenesis of the epiblast during this period of human development is poorly 43 understood. Different states of pluripotency maintenance in vitro have been hypothesized to 44 correspond to unique sub-stages of pre-gastrulation epiblast morphogenesis, e.g., with the naïve and 45 primed states representing the pre-implantation and post-implantation epiblast, respectively (3). 46 Pluripotency markers (e.g., NANOG and POU5F1) are expressed in both pre-and post-implantation 47 epiblast and in their corresponding states captured in vitro in the mouse (4). The human epiblast is 48 presumed to behave in a similar way, a concept partially supported by data from prolonged in vitro 49 culture of human blastocyst and from histological analysis of rare, post-implantation stage human 50 embryos (2, 5-7). However, differences between human and mouse development have long been 51 noted, e.g., in topographic arrangement of the epiblast sheet with respect to the rest of the embryo in 52 vivo (8) and in the properties of the embryonic stem cells (ESCs) and induced pluripotent stem cells 53 (iPSCs) cultured in vitro (9). Furthermore, it is unclear whether epiblast's intercellular organization 54 plays any role in regulating its pluripotency in either mouse or human development. Except for germ 55 cells, differentiation into any somatic cell lineage can be achieved from either the naïve or primed ESCs, 56
suggesting that morphogenetic status of pre-gastrulation epiblast is not a key factor in its pluripotency 57 maintenance in vitro. Yet, in all amniote species examined, including the birds and mammals, an 58 epithelialized epiblast is a prerequisite for gastrulation to take place in vivo (8), suggesting that epiblast 59 pluripotency status is causally correlated with its morphogenesis. 60 Epithelialization of mouse epiblast was shown to be dependent on cell-extra cellular matrix (ECM) 61
interactions. Its polarization, for example, was reported to be regulated by Integrin-linked kinase 62 activity, known to bridge β1/2/3-integrin cytoplasmic tail to the actin cytoskeleton (10), and by both 63 β1-Integrin and Dystroglycan, two main types of transmembrane proteins that mediate epiblast-ECM 64 interaction (11). Modulating cadherin-mediated epiblast cell-cell interactions, by either deleting E-65 cadherin or replacing E-cadherin with N-cadherin, also had a profound effect on epiblast cell-ECM 66 affinity (12). Weakening of integrin-mediated cell-ECM interaction led to a reduction in E-cadherin 67 mediated cell-cell adhesion strength (13), indicating that cell-ECM and cell-cell interactions, as well as 68 their crosstalk, are critically involved in epiblast epithelialization (14) . These lines of evidence suggest 69 that polarization of the epiblast, including the establishment of apicobasal polarity and epiblast-ECM 70
interaction and the modulation of epiblast adherens junction, is temporally and morphogenetically 71 involved in epiblast pluripotency regulation. 72
To understand how epiblast morphology regulates its pluripotency, we first investigated whether its 73 epithelialization, from late blastocyst to pre-gastrulation stage, could be viewed as a mesenchymal-74 epithelial Transition (MET) process, the reverse of Epithelial-Mesenchymal Transition (EMT) (15). Using 75 a combination of in vivo (chicken epiblast) and in vitro (human iPSCs [hiPSCs], human ESCs [hESC] and 76 mouse PSCs [mESCs and mEpiSCs]) models, we asked whether epiblast MET played a role in epiblast 77 pluripotency maintenance and if so, how this could offer us insight into normal pre-gastrulation 78 development of the human embryo. We present data showing that amniote epiblast goes through a 79 partial MET process which is primarily characterized by the segregation of basal and lateral plasma 80 membrane domains of the epiblast and by the deposition of epiblast basement membrane. This partial 81
MET regulates the initiation of pluripotency exit through activation of the integrin-mediated signaling 82 pathway. 83
84
RESULTS
85
Avian epiblast undergoes epithelialization and initiates pluripotency exit before the onset of 86 gastrulation 87
Using the analogy of Waddington's epigenetic landscape of lineage specification (16), the loss of 88 pluripotency in amniote (birds and mammals) development is marked by gastrulation, a process in 89 which the epiblast gives rise to the three definitive germ layers (the ectoderm, mesoderm and 90 endoderm). We have previously shown that gastrulation in chick embryos, taking place mainly at 91
Hamburger and Hamilton stages (HH) 3 and 4 (about 12-18 hours of development after egg-laying), 92
requires an epithelial-mesenchymal transition (EMT) process to convert epithelial-shaped epiblast cells 93 into mesenchymal-shaped mesendoderm precursors (17, 18) . We and others have also reported that 94 gastrulation EMT is associated with the loss of pluripotency markers in the epiblast at about stage HH5 95 when neural ectoderm fate is specified (19, 20) . To investigate the dynamic relationship between 96
As shown previously (19), after gastrulation EMT, mesendoderm cells lost their pluripotency marker 149 expression completely ( Fig.S4D ). 150 151
Undifferentiated hiPSCs exhibit a size-dependent shift in macroscopic patterns of pluripotency gene 152 expression 153
Similar to the avian epiblast, mammalian pluripotent cells appear also to undergo an epithelialization 154 process in their morphogenesis, i.e., from non-epithelial epiblast precursors in the inner cell mass to 155 an epithelial epiblast surrounding a proamniotic cavity before gastrulation (29) . We hypothesized that 156 such a partial MET, similar to the case in the chick, is critical for mammalian pluripotency regulation, 157
possibly marking a so far undescribed initiation checkpoint of pluripotency exit. To test this hypothesis, 158
we used cultured human induced pluripotent stem cells (hiPSCs; 201B7 line) (30) as a surrogate for the 159 human epiblast tissue. HiPSCs can be kept in a pluripotent state under maintenance conditions and 160
can give rise to cell lineages in all three germ layers upon receiving differentiation cues. Single-cell level 161 heterogeneity in pluripotency marker expression has been reported for hiPSCs cultured under 162 maintenance conditions (31-33). 163
We first asked whether a similar heterogeneity could be observed at the macroscopic level. To reveal 164 dynamic changes in gene expression, we used the RNA in situ hybridization method and analyzed 165 expression patterns of key pluripotency regulatory genes POU5f1, NANOG, LEF1 and OTX2 in hiPSCs 166 (Materials and Methods; Fig.2A ). For all four genes, we observed two types of hiPSC colonies ( Fig.2A ), 167 one with a ubiquitous and centrally-high expression [referred to as center (+) colonies in this work] 168 ( Fig analysis revealed that center (+) colonies were generally smaller (with a colony radius of 304.6 +/-12.3 171 m and n=53 for POU5F1) than the center (-) ones (with a colony radius of 553.7 +/-27.6 m and n=30 172 for POU5F1) ( Fig.2A,B) . Similarly, a strong size-pattern correlation was observed for the other three 173 genes ( Fig.2B ). To understand this dynamic shift in more detail, we divided each POU5F1-stained 174 colony into sub-territories as schematized in Fig.2C and analyzed their correlation with the colony size 175 (Fig.2D ). The center (-) territory was strongly correlated with the overall colony size ( Fig.2D green) 176
(Pearson correlation coefficient r= 0.88; two-tailed t-test p< 0.001). A clear correlation (r= 0.72, p< 177 0.001) was also seen between the colony size and the width of POU5F1-positive territories [center (+) 178 region in small colonies and pericenter (+) region in big colonies as shown in Fig.2D ], with an initial 179 positive association (up to 450 µm in colony size) and a gradual shift to a steady state width of 180 approximately 150 µm ( Fig.2D blue) . On the contrary, no correlation between the colony size and the 181 edge territory was observed (r=0.22, p=ns) ( Fig.2C; Fig.2D purple). This overall dichotomy in expression 182 patterns was further supported by POU5F1 and NANOG immunofluorescence analysis ( Fig.2E ). Taken 183 together, these data suggested that hiPSCs cultured under pluripotency maintenance conditions 184 undergo a macroscopically predictable change in pluripotency gene expression during their expansion 185 from a few cells to a colony of hundreds of cells before passaging. 186
Reduction in pluripotency gene expression in hiPSC colonies is a reversible process with no loss of 187
pluripotency after re-culture 188
To test whether reduced pluripotency gene expression in center (-) colonies was indicative of an 189 irreversible pluripotent loss, we isolated center and pericenter cells through laser microdissection 190 ( Fig.2F ) (materials and methods). Isolated cells were treated with ROCK inhibitor Y-27632 for 2h before 191 dissociation and re-culture in normal maintenance media. Both center-derived and pericenter-derived 192 hiPSCs were capable of growth and re-formation of the originally patterned colonies ( Fig.2G ) with no 193 significant difference in either the total cell number ( Fig.2H ) or colony number ( Fig.2I ) after re-culture. 194
When large colonies were micro-dissected to remove pericenter cells, leaving only center (-) cells 195 ( Fig.2K, top) , such colonies were able to reform large and patterned colonies after continuation of the 196 culture without passaging (Fig.2K, bottom) . Similarly, bisected colonies (with half of the colony 197 removed) were also able to re-establish patterning after continuation of the culture (Fig.2J ). Those 198 data showed that hiPSCs located in the colony center, although having much reduced levels of 199 pluripotency gene expression, still retained their pluripotency and that such pluripotency could be 200 manifested after dissociation or disruption of original colony organization. However, center and 201 pericenter cells did exhibit biased differentiation capability ( Fig.2L ). When we collected micro-202 dissected center and pericenter cells for direct differentiation (Materials and Methods), pericenter 203 cells had full capability (compared with non-dissected hiPSC colonies) to differentiate into the three 204 germ layers, whereas center cells had reduced capability to differentiate into mesoderm fate ( Fig.2L ). 205
The decrease in hiPSC pluripotency is correlated with an increase in its epithelialness 206 Full pluripotency loss takes place during gastrulation EMT. Our data on the chicken epiblast suggested 207 that an important landmark of pluripotency exit is the transition from a non-epithelial epiblast to an 208 epithelial epiblast (i.e., epiblast MET rather than EMT). We asked whether this macroscopic shift in 209 pluripotency gene expression in hiPSC colonies described above was correlated with changes in their 210 epithelial status. Close observation indicated that in small colonies, cells in the center were loosely 211 packed ( Fig.3A,C) . In large-sized colonies, only colony-pericenter cells showed similar loose packing, 212
whereas colony-center cells were arranged tightly ( Fig.3B,D) . This was supported by histological 213 sections of hiPSC colonies cultured on polycarbonate membrane ( restricted to the basal side because little intercellular space was observed at the apical side of either 220 tightly-packed cells in the center (Fig.3F , left) or loosely-packed cells in the pericenter (Fig.3F, right) . 221
Similar to the temporal progression of epithelial maturation described in the avian epiblast ( Fig.1 ), a 222 spatial progression of epithelial maturation was seen in hiPSCs ( Fig colony center cells, but not pericenter cells. Interestingly, apical membrane marker aPKC did not 230 exhibit prominent difference in either expression level or localization between center and pericenter 231 cells ( Fig.3L ), suggesting that the pericenter cells, although not fully epithelial, exhibit partial epithelial 232 characteristics and that these cells will progressively mature into a full epithelium as the colony 233 expands. Collectively, these data showed that hiPSCs under pluripotency maintenance culture 234 conditions undergo a partial MET that is correlated with a reduction in their pluripotent gene 235 expression. Taking both chick epiblast and hiPSC data into consideration, we called this phenomenon 236
MET-associated initiation of pluripotency exit in order to distinguish it from the loss of pluripotency 237 associated with gastrulation EMT. 238 239
Perturbation of MET alters initiation of pluripotency exit 240
To test whether the association between MET and pluripotency is causal, we used the Rho-kinase 241 inhibitor Y-27632 to perturb the MET process. We have previously shown that the activity of small 242
GTPase RhoA is essential for the maintenance of epithelial status of the epiblast during gastrulation 243 EMT (17). Y-27632, a potent inhibitor of Rho-associated protein kinases and of RhoA activity, was 244 reported to increase the survival of dissociated hiPSCs without significantly altering their pluripotency 245 status (36). After 48 hours of Y-27632 treatment (20µM; from day 4 to day 6 of culture), cells in the 246 center of hiPSC colonies adopted a loosely-packed morphology (Fig.3E , bottom panel) compared to 247 the control ( Fig.3E , middle panel), suggesting that the process of partial MET in the colony center was 248
inhibited. Statistical analysis revealed that Y-27632 also caused a reduction in hiPSC's height ( Fig.4A ; 249 black control r=0.82 p<0.001, blue Y27632 r=0.50 p<0.001) and height heterogeneity (measured by 250 max/min cell height ratio; Fig.4B ; black control r=0.81 p<0.001, blue Y27632 r=0.20 p=ns). We then 251 asked whether Y27632 could affect pluripotency exit as described above. After either 24 hours (day 5 252 to 6) or 48 hours (day 4 to 6) treatment with Y-27632, iPSC colonies were analyzed for POU5F1 253 expression. Two types of POU5F1-expressing colonies were observed in both cases ( Fig.4C ), similar to 254 the control. A dramatic increase in colony size, however, was observed after both 24 hour and 48 hour 255 treatment and in both colony types ( Fig.4D for center-positive colonies and Fig.4E for center-negative 256 colonies), consistent with the reduction in cell-cell compactness ( Fig.3E ) and cell height ( Fig.4A,B ). 257
Moreover, in the 24 hour treatment group, the relative ratio of center-negative and pericenter-positive 258 territories in large colonies was changed ( Fig.4C ,F), resulting in an increase in the POU5F1-positive 259 pericenter territory at the expense of POU5F1-negative one ( Fig.4C ,F; green: 24 hour-treated; blue: 260 control). This increase in the POU5F1-positive pericenter territory was correlated with the increase in 261 the overall colony size (r=0.72 p<0.001) ( Fig.4F ). These observations were further supported by the 262 analysis using POU5F1 and NANOG antibodies ( Fig.4G ). In the 48 hour treatment group, the size of 263 POU5F1-positive territory became variable and lost any correlation with the colony size (r=0.21, 264 p<0.05) ( Fig.4C,F) , although a mild increase throughout the colony in POU5F1 expression levels was 265 observed for this group (Fig.4C ). To test whether such perturbation of patterning was specific to Y-266 27632, we cultured hiPSCs for six days (the entire duration of culture) under hypoxia (5% O2), which 267 had been reported to promote pluripotency maintenance in ESCs (37, 38). Hypoxia caused a small 268 increase in overall colony size ( Fig co-immunofluoresence analysis of hPAR1b-TA (revealed by antibody against His-tag) and NANOG 289
showed that no significant change in pluripotency level could be associated with increased cell height 290 ( Fig.4I ). Neither wild type hPAR1b (hPAR1b-WT) nor a kinase-dead mutant of hPAR1b (hPAR1b-KM) 291
had a clear effect on either cell height ( Fig.4H ,J,K) or pluripotency marker level ( Fig.4I ). These data, 292
together with our observation that in both chick epiblast ( Fig.1 ) and hiPSC colonies ( Fig.3 ) the apical 293 domain marker aPKC was already correctly localized at the immature epithelial stage, suggested that 294 the segregation of apical and basolateral membrane domains was not a key factor in this partial MET 295 or pluripotency exit. 296
Integrin-mediated compartmentalization of lateral and basal domains regulates pluripotency exit 297
We then asked whether subdivision of the basolateral domain into basal and lateral domains, 298 mediated by dynamic interplay between cell-matrix and cell-cell contacts, could play a role in 299
pluripotency exit. We first tested the effect of nocodazole on pluripotency gene expression. 300
Nocodazole can destabilize microtubule network and lead to basement membrane degradation of 301 chicken epiblast cells during gastrulation EMT at stage HH3/4 (17, 40), potentially erasing the 302 difference between the basal and lateral membrane domains. However, nocodazole was also shown 303
to reduce pluripotency marker expression through an upregulation of TP53 in ESCs (41). Treatment of 304 stage HH1 embryo with nocodazole (3 hours; 10 g/ml) led to disruption of epithelial integrity and to 305 a modest decrease in NANOG protein expression levels ( Fig.S4E,F ). HiPSCs treated with nocodazole (10 306 g/ml) for 24 hours resulted in their detachment from the dish. When treated for 3 hours (10 g/ml), 307 it caused a mild, but statistically significant drop in NANOG and POU5F1 expression levels ( Fig.4L ; 308 Fig.4M , red: nocodazole, blue: control. N=3). NANOG and POU5F1 intensities showed tight correlation 309 in both control and nocodazole treated groups (Fig.4N ), except for a small population of mitotically 310 arrested cells ( Fig.4O , right) which had a strongly reduced level of POU5F1 expression ( Fig.4N,O) . Taken  311 together, these data suggested that microtubule destabilization had a complex, but not prominent, 312 effect on hiPSC pluripotency exit. 313
We next tested whether integrin-mediated cell-matrix interaction played a role in pluripotency exit. 314
Both chicken epiblast and hiPSCs expressed β1 integrin as the major β isoform ( Fig.1C; Fig.5A ; Sup-315
Table3). The blocking antibody for β1 integrin (P5D2; Materials and Methods) would block β1 integrin-316 mediated cell-matrix interaction, but not the E-cadherin mediated cell-cell interaction. 24 hour-317 treatment with the blocking antibody (1 µg/ml) led to complete detachment of hiPSCs, suggesting that 318
it had a potent effect on cell-matrix interactions. 2 hour-treatment of β1 integrin blocking antibody (1 319 µg/ml) did not cause obvious morphological abnormality, but resulted in a robust upregulation of 320 POU5F1 expression in all colonies and erased the center (-) territory in large colonies ( Fig.5B ), 321
suggesting that integrin mediated cell-matrix interaction was a key regulator of pluripotency exit. 322
Prolonged treatment (48 hours) of hiPSCs with much lower concentrations of β1 integrin blocking 323 antibody (10 ng/ml and 24 ng/ml), however, resulted in reduction in pluripotency marker expression 324 ( Fig.5C ). Interestingly, both concentrations (10 ng/ml and 24 ng/ml) of blocking antibody treatment 325 also led to an increase in colony sizes [both center (+) and center (-) types] ( Fig.5D ), indicating a "delay" 326 in the timing of the appearance of patterning. Conversely, treatment with an integrin beta1 activating 327 antibody (P4G11; Materials and Methods) reduced the colony sizes when patterning started to emerge 328 ( Fig.5E ). Collectively, these data suggested that integrin-mediated signaling played a positive role in 329 promoting the pluripotency exit. We next asked how E-cad mediated cell-cell interaction was involved 330 in this process. HiPSC colonies treated with EGTA (2mM) for 20 minutes stilled retained overall integrity 331 ( protein in Fig.5N ). 348
MET-mediated hiPSC pluripotency exit involves canonical EMT/MET transcriptional regulator 349
Above data suggested that epiblast pluripotency regulation is tightly coordinated with epiblast MET 350 regulation. As in any EMT/MET process, epiblast MET is presumed to be under stereotypic 351 transcriptional regulation. Among the core EMT/MET regulators (SNAI1, SNAI2, ZEB1, ZEB2, TWIST1  352 and TWIST2) (43), data from geo-profiles suggested that SNAI1, ZEB1 and ZEB2 were highly expressed 353 in hiPSCs (44). We confirmed high expression of SNAI1 in hiPSCs by RNA in situ hybridization analysis 354 ( Fig.6A ). Interestingly, SNAI1 expression also showed robust patterning in large colonies ( Fig.6A,  355 middle), similar to that of pluripotency markers. SNAI2 expression was very low or negative in hiPSCs 356 (Fig.6A, right) . This colony-size dependent patterning of SNAI1 expression was also seen at the protein-357 level, with pan-colony expression in smaller colonies (Fig.6B , top) and patterned (center-low and 358 periphery-high) expression in larger ones (Fig.6B, bottom) . Aside from the core EMT/MET transcription 359 factors, additional transcriptional regulators are known to play a role in EMT/MET in a process-specific 360 manner and we tested three (GRHL2, YAP and TAZ) among those. GRHL2 was shown to recruit 361 polycomb repressor complex and suppress ZEB1/2 and other EMT-related genes (45-47) and its down-362 regulation was associated with poor prognosis in ovarian cancer patients (45, 48). 363
Immunofluorescence staining showed that GRHL2 was highly expressed in hiPSCs, but without 364 exhibiting marked regional difference ( Fig.6C ). We furthermore tested YAP and TAZ, which are Hippo 365 pathway effectors (49) and are known to be involved in EMT regulation (43). Nuclear localization of 366
YAP was shown to positively control epiblast pluripotency in both human and mouse models (50, 51). 367
Immunofluorescence staining showed that YAP was expressed and localized to the nucleus in all hiPSCs 368 ( Fig.6D) , with a slight decrease in center cells. TAZ was shown to differentially affect primed PSC's self-369 renewal and differentiation via its subcellular localization (52 MMP9 activity was high throughout hiPSC colony ( Fig.6G ), whereas MMP2 activity was relatively weak 377 but detectable ( Fig.6G ). As a negative control, MMP13 activity was not detectable in hiPSCs ( Fig.6G ). 378
However, neither MMP9 nor MMP2 exhibited prominent patterning in their activity distribution, 379
suggesting that MMP activity is not the primary target of epiblast MET regulation. This was supported 380 by the observation that treatment with Marimastat, a pan-MMP inhibitor, did not lead to significant 381 alteration in POU5F1 patterning in hiPSCs ( Fig.6F ). Taken together, these data suggested that several 382 EMT/MET transcriptional regulators are involved in the epiblast MET process. How epiblast MET is 383 transcriptionally regulated remains to be clarified. 384
MET-like colony patterning is also observed in human ESCs, but not in mouse PSCs. 385 We next investigated whether MET-like colony patterning could be observed in other PSCs. Human 386
ESCs (hESCs) were reported to exhibit prepatterning when grown for 24h in micropatterned culture 387 condition (58), with colony size-dependent center-low/periphery-high intra-colony variation in 388 pluripotency marker (NANOG, OCT4 and SOX2) expression. This observation was confirmed when 389 hESCs were cultured in pluripotency maintaining, micropatterned culture condition for either shorter 390 (11h; MP-media11h) or longer (45h; MP-media45h) time period ( These data suggested that intra-colony pre-patterning is a general behavior of human PSCs. Supporting 395 this, hESC colonies also exhibited a prepatterning of EMT/MET marker SNAI1 (Fig.7A,B ), as seen in 396 hiPSC colonies ( Fig.6A,B ). This MET-like prepatterning of hESC colonies under maintenance conditions 397 is likely different from EMT-like behavior of hESCs induced under BMP-induced differentiation (58, 59). 398
Under BMP-induced differentiation, SNAI1 was highly expressed in colony periphery, and pluripotency 399 markers NANOG and SOX2 were markedly reduced in this region (MP-BMP45h; Fig.S6 ). Because SOX2 400 marks both the pluripotent cell population and the neuroectoderm cell lineage, a differentiating hESC 401 colony would show an upregulation, instead of downregulation, of SOX2 in colony center. Under 402 pluripotency maintenance conditions, reduced NANOG and OCT4 expression in colony center was 403 prominent in both hESCs ( Fig.7A ,B) and hiPSCs ( Fig.7C ,D,E) and this was coupled with a mind decrease 404 in SOX2 ( Fig.7) rather than differentiation-associated increase ( Fig.S6 ), suggesting that pluripotency 405 exit is not correlated with spontaneous differentiation. 406
The hiPSCs have a transcriptome profile similar to post-implantation epiblast and EpiSCs (60). In vivo, 407 epithelialization of the epiblast corresponds to developmental progression from pre-implantation to 408 post-implantation epiblast(61). We then asked whether similar prepatterning could be observed in 409
mouse EpiSCs (mEpiSCs). We first checked epithelial status of mEpiSC and mESC colonies ( Fig.S5A,B ). 410 mEpiSC colony (Fig.S5B ) had a single cell-layered structure with well-localized ZO-1 (tight junction) and 411 E-cad (adherens junction) with no obvious regional variation, indicating its full epithelial organization. 412
In contrast, mESC colony had a multilayered structure with irregular E-cad and ZO-1 signals (Fig.S5A ). 413 mESCs had higher levels of expression of pluripotency markers NANOG and POU5F1 at both the protein 414 ( Fig.S5C ) and RNA ( Fig.S5D ) levels. But no intra-colony pre-patterning could be observed in either 415 mEpiSC or mESC colonies. Similar to hiPSCs, GRHL2 was expressed in all cells in both mEpiSC and mESC 416
colonies, but without any overt patterning (Fig.S5E ). Interestingly, we did observe a prominent 417 difference in SNAI1 subcellular localization, with predominantly cytoplasmic localization in mESCs and 418 predominantly nuclear localization in mEpiSCs. Taken together, these data suggested that in mouse 419
PSCs under the current culture conditions, differential epithelialization status and pluripotency level 420
was not reflected as intra-colony prepatterning, but rather as differences in colony morphology and 421 pluripotency regulation between mESCs and mEpiSCs. 422
423
DISCUSSION
424
The avian embryo before gastrulation contains three cell lineages: the epiblast, hypoblast and area 425 opaca (Fig.8A, left) . The first two are equivalent to their mammalian counterparts (Fig.8A, right) . The 426 third anchors the developing embryo to the yolk and stretches the epiblast as it expands over the yolk 427 surface. The area opaca cells are also the evolutionary origin of mammalian trophoblasts. The 428 monotremes, the earliest branched-out extant mammals, for example, still retain an avian-like pre-429 gastrula organization (8). Despite superficial difference in epiblast topography between the chick 430 (exposed to the embryo exterior) and human (covered by polar trophectoderm), epiblast cells in both 431 species undergo a very similar sequence of molecular and morphogenetic events (Fig.8A ). These events 432 include: 1) molecular specification of epiblast precursors; 2) morphological sorting of epiblast-fated 433 cells; 3) full epithelialization of the epiblast (subject of this study); 4) morphogenesis of epithelialized 434 epiblast; 5) dissolution of epithelial structure during gastrulation EMT. It is generally considered that 435 pluripotency loss coincides with the last step in this sequence when mesendoderm cells switch off 436 pluripotency markers after gastrulation EMT and the remaining epiblast cells differentiate into 437 ectoderm derivatives and likewise lose pluripotency. In this work, we demonstrated that there is an 438 additional component of pluripotency regulation which is distinct from gastrulation EMT-related 439 pluripotency loss. We termed this process "pluripotency exit" and its earliest step "initiation of 440 pluripotency exit". We provided evidence that this "initiation of pluripotency exit" is correlated to and 441 regulated by epiblast partial MET (Fig.8A ). This partial MET refers to the transition from an immature 442 epithelioid organization to a fully-epithelial one. Using a combination of avian epiblast and mammalian 443 PSC models, our data suggested that partial MET-mediated pluripotency exit is reversible and is 444 evolutionarily conserved. It is primarily regulated through the specification of epiblast's basal 445 membrane domain and by Integrin-mediated epiblast-extracellular matrix signaling. 446
The process of epiblast pluripotency exit described in this work is likely different from the "naïve-to-447
primed" transition that has been reported in the mouse (62) (Fig.8B) . The basic distinctions between 448 these two in vitro (naïve and primed) states of pluripotency are their in vitro culture conditions and in 449 vivo reconstitution potentials. The naïve state has been hypothesized to represent the pre-450 implantation epiblast, whereas the primed state the post-implantation one (3). Cell biological studies 451
suggest that this transition is associated with polarization of the mouse and human epiblast (62). 452
However, our study showed that in both chicken epiblast at EGK-X (oviposition stage) and young hiPSC 453 colonies, the pluripotent stem cells are already polarized in their apical-basolateral axis, suggesting 454 that the starting point of our analysis is a primed-like state of pluripotency. This hypothesis is 455 supported by molecular data from hiPSCs (showing a primed pluripotency signature) and from our 456 comparative analysis of pluripotency markers in two avian species, the zebra finch (oviposition at stage 457 EGK-Vl; with a prominent naïve pluripotency signature) and chick (oviposition at stage EGK-X; with a 458 primed pluripotency signature) (21). Despite such distinctions, the "naïve-to-primed" transition and 459
the "pluripotency exit" reported here likely represent the same sequence of events in epiblast MET 460 (Fig.8A,B) , with the former corresponding to the first half of MET (from non-polarized epiblast to 461 polarized epiblast) and the latter to the second half (from polarized epithelioid epiblast to fully 462 epithelial epiblast). More importantly, it is worth noting that epiblast MET, including both components 463 discussed above, is different from the pluripotency loss seen during gastrulation EMT, and that these 464 two morphogenetic events are separated by a wide (in developmental terms) temporal window during 465 which epiblast cells are known to undergo additional intra-and inter-cellular morphogenesis while 466 keeping their epithelial status. One of the most important patterning events in early amniote 467 development, the radial-symmetry breaking which determines the future embryonic dorsal-ventral 468 axis, takes place during this interval period. It remains to be demonstrated whether there are 469 additional molecular checkpoints between the MET and EMT processes discussed above. A possible 470 scenario is that in vivo, as has been proposed for pluripotent cells cultured in vitro (63) and supported 471 molecularly by the presence of many microstates during ESC differentiation into neuronal lineage (64), 472 a continuum of regulatory steps will be uncovered. 473
A key component of this MET-associated pluripotency exit is the integrin-mediated cell-matrix 474 signaling. Such signaling requires the deposition of basement membrane proteins, as shown in this 475 work for both the chicken epiblast and hiPSC, and the segregation of basal and lateral membrane 476 domains of the pluripotent cells. We have previously shown that during chicken gastrulation EMT, 477 epiblast cells interact with their basement membrane through Integrins and Dystroglycan (18, 40). This 478 interaction compartmentalizes the basolateral domain of an epiblast cell into separate basal and 479 lateral domains and restricts functions of cell-cell interaction molecules (e.g., E-cad) to the lateral 480 domain and cell-matrix interaction molecules (e.g., Integrins and Dystroglycan) to the basal one. We 481 confirmed that Dystroglycan was also expressed in pre-gastrulation epiblast cells ( Fig.1D ) and in hiPSCs, 482
although in this work we did not focus our study on the function of Dystroglycan in pluripotency exit. 483
Among the Integrins, in both gastrulation stage epiblast (40) and pre-gastrulation stage epiblast (22) 484 (Sup-Table3), ITGB1, ITGB5 and ITGB3 are the major beta subunits and ITGAV and ITGA6 are the major 485 alpha subunits. Interestingly, Integrin profiling of 201B7 line (Sub-Table3) suggests that such 486 heterogeneity is conserved in hiPSCs, which express ITGB1, ITGB5, ITGAV, ITGA6 and ITGAE as their 487 major alpha and beta subunits, respectively. Involvement of Integrin signaling in pluripotency cell 488 maintenance has been reported. For example, Integrin-mediated focal adhesion kinase activity was 489
shown to protect hESCs from apoptosis and differentiation (65) and alphavbeta5 Integrin was shown 490 to support self-renewal of hESCs (66). Furthermore, alpha6beta1 was shown to mediate laminin-511 491 supported renewal of hESCs and hiPSCs (67), but likely through alpha6-mediated suppression of beta1 492
Integrin activity, as activation of beta1 Integrin or knockdown of apha6 Integrin led to a reduction of 493 pluripotency marker expression (68). Supporting this, inhibition of Integrin signaling by disintegrin 494 could promote pluripotency maintenance of mouse iPSCs (69). In our work, brief suppression of 495
Integrin signaling using high concentrations of beta1 Integrin blocking antibody resulted in a dramatic 496 increase in pluripotency level and in the blockage of pluripotency exit (Fig.5B ) and brief activation of 497
Integrin signaling using Mg2+ and Mn2+ cations led to pluripotency exit in both hiPSCs ( Fig.5F ) and 498 chicken embryos (Fig.5K,N) , strongly suggesting that MET-associated pluripotency exit observed in our 499 model systems is positively regulated by Integrin signaling. However, our results also pointed to a 500 putatively positive role of Integrin signaling in pluripotency maintenance, because long-term 501 treatment of low concentrations of beta1 Integrin blocking antibody resulted in a reduction of 502 pluripotency marker expression ( Fig.5C ). Future experiments on how Integrin signaling is transmitted 503 intracellularly to regulate the pluripotency network will be needed to clarify such discrepancy. 504
Our work is the first to associate epiblast cell morphology with epiblast pluripotency exit in embryonic 505 epiblast and cultured PSCs. It is unclear whether this phenomenon can be generalized to all cultured 506 pluripotent cells that adopt an epithelial-like colony structure during their maintenance phase or 507
whether it reflects intrinsic morphogenetic behavior of their developmental origin, the epiblast. We 508 did not observe intra-colony MET in mEpiSCs, although these cells adopt a perfect epithelial 509 morphology throughout the colony. Such species-specific difference may be due to difference in 510 culture conditions, but it also suggests that morphological feature is not a sole indicator of variability 511 in the pluripotency spectrum. Patterned heterogeneity in pluripotency marker expression was 512
proposed to facilitate higher-order patterning under differentiation conditions in human ESCs and 513 mouse epiblast-like cells (58, 59, 70), possibly by facilitating lineage specific gene expression through 514 GRHL2-mediated enhancing switching in the regulation of pluripotency genes (71). As MET-like pre-515
patterning was also observed in hESC colonies, it would be interesting to test in the future whether 516 difference in differentiation potentials can also be associated with cells isolated from sub-regions of 517 hESC colony with different epithelialization status and EMT/MET marker expression levels. Such a 518 hypothesis is supported by a recent paper which showed that intra-colony difference in cellular 519 adhesive properties defines a potential N-cadherin+ founder cell population within primate PSC 520 colonies (72). 521
More importantly, as we have demonstrated, pluripotency exit is reversible and is different from 522 pluripotency loss seen during gastrulation in vivo or under differentiation conditions in vitro. For 523 ectoderm-fated epiblast cells, the MET is clearly necessary because both neural ectoderm and non-524 neural ectoderm cells adopt a fully epithelial morphology after gastrulation. For those epiblast cells 525 which will eventually give rise to the mesoderm and endoderm germ layers during gastrulation, they 526 will have to undergo an MET to achieve full epithelial status only to be followed by a full EMT and loss 527 of their pluripotency. The biological significance for such morphogenetic behavior is unclear because 528 in vitro, lineage differentiation into the three germ layers can be achieved from pluripotent cells 529 regardless of their epithelialization status (Fig.8B ). Although the term epiblast generally refers to 530 pluripotent cells in amniotic vertebrates (birds, reptiles and mammals), pluripotency regulatory 531 network has deep evolutionary root (73) and similar pluripotent cells also exist in the anamniotic 532
vertebrates [e.g., in zebrafish (74, 75)]. It is therefore interesting to note that full epithelialization of 533 pre-gastrulation pluripotent cells only occurs within the amniote clade (8, 76). This suggests that 534 epiblast MET is associated with certain amniote-specific developmental features which require 535 epithelial structure-based intercellular signaling or force transmission [e.g., epiblast cell intercalation 536 and polonaise movement reported in the pre-gastrulation chick embryo (77-79)]. These epithelial 537 structure-based cellular events are known to be directly involved in the formation of the primitive 538 streak (an amniote-specific feature) or more generally, of a posterior epiblast-restricted center of 539 mesendoderm internalization (i.e., of later-on gastrulation EMT). Therefore, epiblast MET is not only 540 important for epiblast pluripotency regulation as described in this work, but likely also for epiblast 541 planar symmetry-breaking. How these two phenomena are linked developmentally remains to be 542 clarified. 543
544
MATERIALS & METHODS
545
Array analysis of chicken area pellucida samples 546
Fertilized chicken eggs purchased from a local farm (Shiroyama farm, Kanagawa, Japan) were 547 incubated without storage at 38.5°C for 0.5, 5.5, 9 and 14 hours. The area pellucida (AP) region of the 548 embryos, containing both the epiblast and hypoblast, but excluding the primitive streak region for 9 549
and 14 hour sample sets, was cut out in Pannett-Compton solution. Dissected AP samples of specific 550 time points were pooled and used for RNA isolation. Two independent sets of total RNA from pooled 551 AP samples were isolated using QIAGEN RNeasy Micro Kit. 100 ng of quality checked total RNAs were 552 used for array analysis, with the cDNA synthesis and cRNA labeling reactions performed according to 553 the two-cycle protocol provided by Affymetrix. Affymetrix high-density oligonucleotide arrays for 554
Gallus gallus (GeneChip ® Chicken Genome) were hybridized, stained, and washed according to the 555 Expression Analysis Technical Manual (Affymetrix) and analysis of resulting expression values was 556 performed as described previously (80). Array raw data have been deposited in public database with 557 the accession number GSE114476. 558 559
hiPSC culture and reagents 560
The hiPSC line 201B7 (purchase from RIKEN BRC Cell Bank)( was used for all experiments. Cells were 561 maintained in an undifferentiated state on iMatrix-511 (0.5 µg/cm 2 ; Nippi, Japan; #892018)-coated 562 dish using the StemFit AK02N (Ajinomoto) medium and cultured at 37 °C with 5% CO2. At Day 7 of 563 culture, hiPSC colonies were dissociated using accutase (Nacalai tesque, Japan; #12679-54) and 564 unicellular hiPSCs were then seeded on new culture dish freshly coated with iMatrix-511, in a medium 565
containing 10 μM Y-27632 (Wako Pure Chemicals Industries, Japan; #253-00513). All experiments in 566 this study were performed at day 6 of culture, one day before normal passaging. For pattern alteration 567 experiments, Y-27632 was used at a concentration of 20 µM, MMP broad spectrum inhibitor 568
Marimastat (a gift from Prof. Hiroshi Sato, Kanazawa University) at 150 nM, nocodazole (Wako #140-569 08531) at 10 µg/ml, EGTA (Sigma #E3889) at 2 mM, MgCl2 (Sigma #1901905) at 5 mM when alone or 570 at 2.5 mM when associated to MnCl2 (2.5mM; Wako #139-00722), and NaCl at 5 mM (Wako #195-571 01663). Monoclonal antibody against β1-Integrin (inhibiting antibody clone P5D2 or activating 572 antibody clone P4G11; Developmental Studies Hybridoma Bank #AB528308 or #AB528307) was added 573
to the culture media either at day 4 of culture at the concentration of 10 ng/ml and 25 ng/ml or for 574 only 2h prior to fixation at 1 µg/ml. These antibodies were also added to PBS (-) supplemented with 575 2.5 mM of MgCl2. 576 577 hESC culture 578 ES017 hESCs were grown in mTeSR1 (STEMCELL Technologies) in tissue culture dishes coated with 579
Matrigel (Corning; 1:200 in DMEMF12) overnight at 4°C. Cells were passaged using dispase (STEMCELL 580 Technologies) every 3 days. Cells were routinely tested for mycoplasma contamination and found 581 negative. Micropatterning experiments were also performed with mTeSR1 following the protocol 582 previously described (2). Where indicated, cells were treated with 50 ng/ml BMP4 to induce 583 differentiation. 584 585 mPSC culture 586
The mESC line EB5 was grown on 0.1% gelatin-coated dishes in a medium consisting of GMEM 10% 587 knock-out serum replacement, 1%FBS, 1 mM sodium pyruvate (Wako #190-14881), 1x non-essential 588 amino acids (Sigma #M7145) and LIF 1000u/ml. Cells were passaged every three days using accutase. 589
The mEpiSC line (81) was grown on 0.5 µg/cm 2 iMatrix-511 (Nippi, Tokyo, Japan) coated dishes in a 590 medium consisting of DMEM-F12, 20% knock-out serum replacement, 1 mM sodium pyruvate, 1x non-591 essential amino acids, 10 −4 M 2-ME, 10 ng/mL activin A (R&D Systems #338-AC), 5 ng/mL human 592 recombinant FGF2 (R&D Systems #3139-FB) and 10µM of XAV939 (Abcam #ab120897). Cells were 593 passaged every 4-5 days using accutase for single cell dissociation. 594 595
Laser microdissection 596 hiPSC colonies were grown on plasma treated glass bottom dish coated with iMatrix-511. At day 6 597 periphery and center of patterned colonies were separated using the laser beam of a Zeiss PALM 598 microbeam. Following laser microdissection, both regions were isolated manually under a microscope. 599
Selected cells were treated with Y-27632 for 2h prior to dissociation and re-plated either at a density 600 of 200 cells/cm 2 for pluripotency assessment experiments or at 400 cells/well (Prime Surface 96V  601 Sumilon Sumitomo Bakelite, Wako #MS-9096V) for differentiation experiments. 602 603 hiPSC differentiation and PCR analysis 604
After five days of culture, newly formed embryoid bodies differentiation was induced by replacing 605 maintenance media with DMEM 10% FBS. After three days, samples were collected for RNA extraction 606 (RNeasy micro Kit, QIAGEN) along with MCF-7, HepG2, HUVEC and undifferentiated hiPSC that were 607 used as positive and negative controls. PCR was performed by using the following primers, human 608 GAPDH: 5'-TCATCCCTGAGCTGAACGGG-3' (forward) and 5'-TCCCCTCTTCAAGGGGTCTACA-3' (reverse); 609
human NESTIN: 5'-CAGGGTTGGAACAGAGGTTGG-3' (forward) and 5'-GCATCTACAGCAGGAGAGGGTG-610
3' (reverse); human SOX1: 5'-CGGAGCTCGTCGCATTTGTT-3' (forward) and 5'-611
TCCCCGGGGTTCCCTTACTT-3' (reverse); human PAX6: 5'-CACCCGCCCTGGTTGGTATC-3' (forward) and 612 5'-TGAGGGCTGTGTCTGTTCGG-3' (reverse); human FOXA2: 5'-AGCGGTGAAGATGGAAGGG-3' (forward) 613
and 5'-ATGGCCATGGTGATGAGCGA-3' (reverse); human T: 5'-CCGAGAGCGCGGGAAAGAG-3' (forward) 614
and 5'-TCACTATGTGGATTCGAGGCTCAT-3' (reverse); human HAND1: 5'-TTAACAGCGCATTCGCGGAG-3' 615 (forward) and 5'-CGTGCGATCCAAGTGTGTGG-3' (reverse); human EOMES: 5'-616 ACACTTTACCTCAAGCCCGC-3' (forward) and 5'-AGTTGCTAGGAGACAGCCGC-3' (reverse); human 617 GATA4: 5-'GTCCCAGTGCAGACCTGCTG-3' (forward) and 5'-CCCTGAGGCTGTAGGTTGTGT-3' (reverse); 618 human CDX2: 5-'CTTCCTGCGCTTCTGGGCT-3' (forward) and 5'-CCAGGCACTGAGGCTTGC-3' (reverse). 619 620
In Situ-Hybridization 621
Probes used for In Situ-Hybridization (ISH) were obtained by RT-PCR using the following primers for 622 human NANOG: 5'-GTGTGGATCCAGCTTGTCC-3' (forward) and 5'-GTCACACCATTGCTATTCTTC-3' 623 (reverse) 493bp; human POU5F1: 5'-CAAGAACATGTGTAAGCTGCGG-3' (forward) and 5'-624 AGGAGTACAGTGCAGTGAAGTG-3' (reverse) 425bp; human LEF1: 5'-CCAGACAAGCACAAACCTCTC-3' 625 (forward) and 5'-AGCCAAGAGGTGGGGTGATC-3' (reverse) 420bp; human OTX2: 5'-626 GAGAGGACGACGTTCACTC-3' (forward) and 5'-TCTGACAGTGGGGAGATGG-3' (reverse) 365bp, human 627 SNAI1: 5'-TGCCTCGACCACTATGCCG-3' (forward) and 5'-AGGCTCGAAAGGCCTTCAACT-3' (reverse) 628 479bp; human SNAI2 5'-TTCGTAAAGGAGCCGGGTGAC-3' (forward) and 5'-629 ATCTTTGGGGCGAGTGAGTCC-3' (reverse) 425bp; human CLDN6: 5'-ACTCGGCCTAGGAATTTCCCTT-3' 630 (forward) and 5'-TAATCCCCGTGTGCTGGACG-3' (reverse) 473bp; human MMP2: 5'-631 TCTTTGGACTGCCCCAGACA-3' (forward) and 5'-AGTACTCCCCATCGGCGTTC-3' (reverse) 447bp; human 632
MMP9 5'-AAGGCCAATCCTACTCCGCC-3' (forward) and 5'-AGGGCGAGGACCATAGAGGT-3' (reverse) 633 445bp; mouse POU5F1 5'-CAGGACATGAAAGCCCTGCAGAA-3' (forward) and 5'-634
GCCCAAGCTGATTGGCGAT-3' (reverse) 397bp; and mouse NANOG 5'-CTGGGAACGCCTCATCAATGC-3' 635 (forward) and 5'-TACTCCACTGGTGCTGAGCC-3' (reverse) 469bp. In situ-hybridization was performed 636 as described previously for chick embryos (82) with slight adaptation in incubation time or 637 concentration of reagents. More specifically, cultured cells were fixed in 4% paraformaldehyde 638 overnight at 4°C. Permeabilization step was performed using 1 µg/ml proteinase K incubation for 20 639 minutes at room temperature, followed by post-fixation for 15 minutes, prehybridization at 68°C for 3 640 hours, and hybridization with gene specific antisense DIG labelled probes at 68°C overnight. After 641 hybridization, samples were washed in prehybridization solution at 68°C and then in TBST at Room 642 temperature. This was followed by 1 hour of blocking at RT, overnight incubation in anti-DIG antibody 643 solution (1/2000; Roche #11093274910) at 4°C. Finally, after several washing steps in NTMT solution, 644 hiPSC colonies were processed for color development in NBT and BCIP at room temperature shielded 645 from light. Whole mount in situ hybridization with chicken embryos for Nanog mRNA detection was 646 carried out as previously decribed (82) and probe information for chicken Nanog was reported 647
previously (19) . 648 649
Imaging and Immunofluorescence staining for PSCs 650
All immunofluorescence experiments were performed using cells grown on plasma treated glass 651 bottom dish. The following primary antibodies were used for NANOG (1:500; ReproCELL #RCAB004P 652 Synthesis and characterization of MMP-2, -9, and -13 peptide sensors 705
The MMP sensors consist of MMPs peptide substrate, fluorescence dye (Cyanine 5.5,Ex/Em 675/690 706 nm), and dark quencher (BHQ-3, abs 650 nm). The MMP-2, -9, or -13 sensor was prepared as previous 707 described (56, 57). Briefly, Cy5.5 succinimide ester and BHQ-3 succinimide ester was conjugated to the 708 MMP-2 [Gly-Pro-Leu-Gly-Val-Arg-Gly-Lys-Gly-Gly], MMP-9 [Gly-Lys-Gly-Pro-Arg-Ser-Leu-Ser-Gly-Lys-709
Gly-Gly], and MMP-13 [Gly-Val-Pro-Leu-Ser-Leu-Thr-Met-Gly-Lys-Gly-Gly] substrate, respectively, and 710 purified by reverse-phase high-performance liquid chromatography (RP-HPLC). The sensors specificity 711 was confirmed by activated recombinant enzymes (MMP-1, -2, -3, -7, -9, -10, and -13) and fluorescence 712 signal was detected using fluorometer. 713
Statistical Analysis 714
Results were expressed as mean ± SEM. Un-incubated embryo (EGK-X/XI) stained for tight junction marker ZO-1 (E), apical marker aPKC (G), 747
FIGURE LEGENDS
Golgi marker GM130 (I) and acetylated tubulin (K). (F, H, J, L): Embryos incubated for 6 hours (EGK-748 XIII/XIV) stained for tight junction marker ZO-1 (F), apical marker aPKC (H), Golgi marker GM130 (J) and 749 acetylated tubulin (L). All markers were co-stained for Laminin (red) and DAPI (cyan). 750 apicobasally-polarized epiblast, to fully epithelial epiblast. Epiblast cells are considered to be 889 pluripotent in all these MET phases. A precise one to one correlation of in vivo cell biological features 890
and in vitro PSC subtypes may not be possible. But the MET step described in this work likely 891 corresponds to the later phase of primed pluripotency status during which a transition from partially 892 epithelialized epiblast to fully epithelialized epiblast takes place, marked by a reduction in pluripotency 893 (e.g., NANOG and POU5F1) and mesenchymal (e.g., SNAI1) regulators. Such epithelization and 894 pluripotency reduction are reversible and epiblast cells at this phase are still considered pluripotent. 895
Gastrulation, coupled with a full EMT, marks the onset of irreversible pluripotency loss. (B) 896
Comparison of the pluripotency exit state described in the work with other known ones, including the 897 naïve, the formative and the primed states. In vivo, it is hypothesized that pluripotent cells transit 898 through those states sequentially. In vitro, however, each state is capable of direct differentiation into 899 three germ layers. The naïve and formative states are also capable of differentiating into the germ cell 900
fate. (C) A summary of molecular and cellular features that define the pluripotency exit state. 901 902 Mouse EpiSCs (mEpiSCs) were organized as an epithleial structure and expressed lower levels of 934 pluripotency markers. Mouse ESCs (mESCs) were organized as a multilayer non-epithelial structure and 935 expressed higher levels of pluripotency makers. (A) mESC colonies were immuno-stained for ZO-1 and 936 CDH1 (E-cadherin). mESC colonies expressed both ZO-1 and CDH1 and exhibited multilayered 937 organization. Both ZO-1 and CDH1 were poorly localized and mESCs were not organized as an epithelial 938 structure. (B) mEpiSC colonies were immuno-stained for ZO-1 and CDH1 (E-cadherin). mEpiSC colonies 939 exhibited single-cell layered epithelial organization, with proper junctional localization of ZO-1 and 940 CDH1. (C) Pluripotency markers (NANOG and POU5F1) did not exhibit intra-colony patterning in mPSCs. 941
SUPPLEMENTARY FIGURE AND TABLE LEGENDS
However, protein expression levels of NANOG and POU5F1 were higher in mESCs than in mEpiSCs. (D) 942
RNA in situ hybridization analysis of NANOG and POU5F1 in mESCs and mEpiSCs. RNA expression levels 943
were higher in mESCs than in mEpiSCs. (E, F) Immunofluorescence staining of mESCs and mEpiSCs with 944 GRHL2 and SNAI1 antibodies. Neither GRHL2 (E) nor SNAI1 (F) showed prominent intra-colony 945 patterning. However, SNAI1 was seen to be localized in the cytoplasm in mESCs and in the nucleus in 946 mEpiSCs. 947 948 Figure S6 : BMP-induced differentiation of micropatterned hESCs. (A) Both NANOG and POU5F1 show 949 strong decrease upon BMP-induced differentiation (compared with expression levels shown in Fig.7B ). 950
In contract, SOX2 shows an increase in colony center upon BMP treatment, marking neuroectoderm 951 lineage differentiation. (B) SNAI1 shows dramatic increase in colony pericenter, after BMP treatment, 952 marking mesendoderm differentiation. 953 954
Table S1: Chicken epiblast Affymetrix genechip data. 955 Table S2 : Gene ontology analysis of significantly changed epiblast genes from HH1 to HH3. 957 958 Table S3: Expression levels of Integrin genes obtained from promoterome and transcriptome  959 analyses. CAGE-based promoter activity data for chicken samples are based on Lizio et al, 2017. 960 Chicken transcriptome data are based on Affymetrix dataset presented in this work. CAGE-based 961 promoter activity data for human iPSCs are based on (85) and human transcriptome data are based on 962
Affymetrix dataset presented in (44). 963 964
